论文部分内容阅读
目的:对患有支气管肺炎的患儿实施盐酸氨溴索雾化吸入治疗,探究其临床治疗效果。方法:选取2014年1月份到2016年3月份收治的600例支气管肺炎患儿作研究对象,将患儿随机分为实验组和对照组,两组均300例。两组患儿均进行常规抗感染+对症治疗外,对照组给予糜蛋白酶治疗,实验组给予盐酸氨溴索雾化吸入治疗。治疗5天后对比两组患儿临床症状、体征消失等情况。结果:实验组患儿治疗后临床症状消失时间短于对照组,实验组治疗总有效率为98.33%,对照组为74.00%,两组对比,差异显著,实验组优于对照组(P<0.05)。结论:将盐酸氨溴索雾化吸入用于小儿支气管肺炎治疗中能够有效改善患儿临床症状,效果显著,值得临床推广使用。
Objective: In patients with bronchial pneumonia, inhalation of ambroxol hydrochloride inhalation to explore the clinical effect. Methods: A total of 600 children with bronchopneumonia admitted from January 2014 to March 2016 were selected as study subjects. The children were randomly divided into experimental group and control group, with 300 cases in both groups. Two groups of children were routine anti-infection + symptomatic treatment, the control group was given chymotrypsin treatment, the experimental group was given ambroxol hydrochloride inhalation therapy. After 5 days of treatment, the clinical symptoms and signs disappeared in both groups. Results: The disappearance time of clinical symptoms in experimental group was shorter than that in control group. The total effective rate was 98.33% in experimental group and 74.00% in control group. The difference between the two groups was significant (P <0.05) ). Conclusion: Ambroxol Hydrochloride inhalation for the treatment of children with bronchial pneumonia can effectively improve the clinical symptoms of children, the effect is significant, worthy of clinical promotion and use.